Eukaryotic expression of the VP1 gene of foot-and-mouth disease virus type O and characterization of expressed fusion protein
Junwei Wang
Abstract
Junwei Wang
Abstract
According to the published VP1 gene sequence,one pair of primers with SacⅠ and HindⅢ endonuclease sites was designed.A VP1 gene in the plasmid pMD18-T-VP1 was subcloned into an eukaryotic vector pBlueBacHis2A,and the recombinant plasmid pBlueBacHis2A-VP1(633bp) was constructed successfully.The plasmid pBlueBacHis2A-VP1(633bp) and Bac-N-Blue~(TM) DNA were co-transfected into sf9 cells.After screening the plaques,sf9 cells were infected with the recombinant virus.The target protein of 32.6ku in size was obtained.Dot-ELISA analysis showed that the protein had good antigenicity.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
According to the published VP1 gene sequence,one pair of primers with SacⅠ and HindⅢ endonuclease sites was designed.A VP1 gene in the plasmid pMD18-T-VP1 was subcloned into an eukaryotic vector pBlueBacHis2A,and the recombinant plasmid pBlueBacHis2A-VP1(633bp) was constructed successfully.The plasmid pBlueBacHis2A-VP1(633bp) and Bac-N-Blue~(TM) DNA were co-transfected into sf9 cells.After screening the plaques,sf9 cells were infected with the recombinant virus.The target protein of 32.6ku in size was obtained.Dot-ELISA analysis showed that the protein had good antigenicity.
Key concepts: Sf9, Recombinant DNA, Molecular biology, Plasmid, Transfection, Antigenicity, Gene, Fusion protein